Edward B Li1, Johanna S Song1,2,3, Jennifer T Huang1,2,4, Elena B Hawryluk1,2,3, Wendy B London1,4, Dongjing Guo4, Madhumitha Sridharan4, David E Fisher1,3, Corinna J Rea1,5, Leslie E Lehmann1,4,6, Christine N Duncan1,4,6. 1. Harvard Medical School, Boston, Massachusetts. 2. Dermatology Program, Boston Children's Hospital, Boston, Massachusetts. 3. Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts. 4. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. 5. Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts. 6. Hematology/Oncology Division, Department of Medicine, Boston Children's Hospital, Boston, Massachusetts.
Abstract
BACKGROUND/ OBJECTIVE: Pediatric hematopoietic stem cell transplantation (HSCT) patients are at an increased risk for skin cancers. Sun exposure is a significant modifiable environmental risk factor. While patient education on sun protection and avoidance behaviors with regular dermatology evaluations are crucial for pediatric HSCT patients, the real-life practice of these sun-protection recommendations in this patient population compared to their peers is unknown. METHODS: A survey-based cross-sectional cohort study was performed in pediatric HSCT patients seen at the Dana-Farber Cancer Institute and Boston Children's Hospital over a 1.5-year period compared with age/sex/Fitzpatrick skin phototype-matched healthy controls. Study participants were surveyed using the validated Glanz survey for pediatric sun protection behavioral research. RESULTS: Eighty-five pediatric HSCT patients and 85 controls completed the study. Pediatric HSCT patients more frequently used sunscreen, hats, umbrellas, and sunglasses and obtained full-body skin exams compared to controls. No difference was observed in sun exposure during hours of peak sun intensity, frequency of purposeful tanning, tanning bed use, and the number of painful sunburns received between pediatric HSCT patients and controls. CONCLUSIONS: Although pediatric HSCT patients practice more sun protection behaviors, they experienced harmful sunburns and intentional tanning behaviors at the same rate as their peers. Patient-directed counseling and strategies to improve patient adherence to optimal sun protection behaviors could have a significant impact on the dermatology quality of life in pediatric HSCT patients.
BACKGROUND/ OBJECTIVE: Pediatric hematopoietic stem cell transplantation (HSCT) patients are at an increased risk for skin cancers. Sun exposure is a significant modifiable environmental risk factor. While patient education on sun protection and avoidance behaviors with regular dermatology evaluations are crucial for pediatric HSCT patients, the real-life practice of these sun-protection recommendations in this patient population compared to their peers is unknown. METHODS: A survey-based cross-sectional cohort study was performed in pediatric HSCT patients seen at the Dana-Farber Cancer Institute and Boston Children's Hospital over a 1.5-year period compared with age/sex/Fitzpatrick skin phototype-matched healthy controls. Study participants were surveyed using the validated Glanz survey for pediatric sun protection behavioral research. RESULTS: Eighty-five pediatric HSCT patients and 85 controls completed the study. Pediatric HSCT patients more frequently used sunscreen, hats, umbrellas, and sunglasses and obtained full-body skin exams compared to controls. No difference was observed in sun exposure during hours of peak sun intensity, frequency of purposeful tanning, tanning bed use, and the number of painful sunburns received between pediatric HSCT patients and controls. CONCLUSIONS: Although pediatric HSCT patients practice more sun protection behaviors, they experienced harmful sunburns and intentional tanning behaviors at the same rate as their peers. Patient-directed counseling and strategies to improve patient adherence to optimal sun protection behaviors could have a significant impact on the dermatology quality of life in pediatric HSCT patients.
Authors: Y Inamoto; N N Shah; B N Savani; B E Shaw; A A Abraham; I A Ahmed; G Akpek; Y Atsuta; K S Baker; G W Basak; M Bitan; Z DeFilipp; T K Gregory; H T Greinix; M Hamadani; B K Hamilton; R J Hayashi; D A Jacobsohn; R T Kamble; K A Kasow; N Khera; H M Lazarus; A K Malone; M T Lupo-Stanghellini; S P Margossian; L S Muffly; M Norkin; M Ramanathan; N Salooja; H Schoemans; J R Wingard; B Wirk; W A Wood; A Yong; C N Duncan; M E D Flowers; N S Majhail Journal: Bone Marrow Transplant Date: 2015-03-30 Impact factor: 5.483
Authors: Lawrence F Kuklinski; Shufeng Li; Margaret R Karagas; Wen-Kai Weng; Bernice Y Kwong Journal: J Am Acad Dermatol Date: 2017-08-02 Impact factor: 11.527
Authors: J S Song; W B London; E B Hawryluk; D Guo; M Sridharan; D E Fisher; L E Lehmann; C N Duncan; J T Huang Journal: Bone Marrow Transplant Date: 2017-04-03 Impact factor: 5.483
Authors: Darren Mays; Jessica Donze Black; Revonda B Mosher; Aziza T Shad; Kenneth P Tercyak Journal: J Cancer Surviv Date: 2011-02-27 Impact factor: 4.442
Authors: June K Robinson; Rob Turrisi; Kimberly A Mallett; Jerod Stapleton; Susan L Boone; Nikki Kim; Nayna Vicky Riyat; Elisa J Gordon Journal: Arch Dermatol Date: 2011-02-21
Authors: Nora B Henrikson; Caitlin C Morrison; Paula R Blasi; Matt Nguyen; Kendall C Shibuya; Carrie D Patnode Journal: JAMA Date: 2018-03-20 Impact factor: 56.272
Authors: Natasha Buchanan; Wendy Leisenring; Pauline A Mitby; Anna T Meadows; Leslie L Robison; Melissa M Hudson; Ann C Mertens Journal: Cancer Date: 2009-09-15 Impact factor: 6.860
Authors: Leslie K Dennis; Marta J Vanbeek; Laura E Beane Freeman; Brian J Smith; Deborah V Dawson; Julie A Coughlin Journal: Ann Epidemiol Date: 2008-08 Impact factor: 3.797